Lightnews — Scholar-powered news

Reposted by Joan Montero

The Society for Functional Precision Medicine @thesfpm.bsky.social · 1d

🚨Excited to announce the seminar by Kushtrim Kryeziu, PhD (Oslo University) on "Functional Precision Oncology for Metastatic Colorectal Cancer". Join us TODAY, at 12 PM EDT, open to everyone! Don't miss it and consider joining the SFPM

www.sfpm.io/seminars

Seminars | SFPM

The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.

www.sfpm.io

1

Reposted by Joan Montero

Universitat de Barcelona @ub.edu · 1d

#RecercaUB | 🧠 Un nou estudi aconsegueix revertir els efectes de l’Alzheimer en ratolins amb l’ús de nanopartícules portadores de molècules terapèutiques.

🔬 Hi han participat Lorena Ruiz Pérez, de #FísicaUB, i Giuseppe Battaglia, tots dos membres @ibecbarcelona.eu.

Aconsegueixen revertir l’alzheimer en ratolins amb l'ús de nanopartícules - Institute for Bioengineering of Catalonia

Un equip internacional codirigit per l'Institut de Bioenginyeria de Catalunya (IBEC) i l'Hospital West China de la Universitat de Sichuan (WCHSU) va poder revertir l'Alzheimer en ratolins després de n...

ibecbarcelona.eu

1 5 21

Joan Montero @joanmontero.bsky.social · 9d

Congratulations Tony! I wish you every success in this new endeavor and I have no doubt that your vision, leadership and integrity will bring great value to the NCI. I'm deeply grateful for your invaluable mentorship, friendship and encouragement over the years. Amazing news!

The Society for Functional Precision Medicine @thesfpm.bsky.social · 9d

We want to congratulate our President, Dr. Tony Letai, on his appointment as Director of the NCI. This announcement marks an historic moment for cancer research. Dr. Letai has been a tireless advocate and visionary leader for functional precision medicine 🧵

www.nih.gov/news-events/...

Secretary Kennedy Swears in Dr. Anthony Letai as Director of the National Cancer Institute

Dr. Letai will serve as NCI’s 18th director.

www.nih.gov

2

Joan Montero @joanmontero.bsky.social · Aug 26

A must watch video: How functional precision medicine could be the future of cancer care. Truly inspiring TED talk by Dr. Diana Azzam

www.youtube.com/watch?v=CqLC...

How functional precision medicine could be the future of cancer care | Dr. Diana Azzam | TEDxMiami

YouTube video by TEDx Talks

www.youtube.com

1

Joan Montero @joanmontero.bsky.social · Jul 22

Moltes felicitats Quim i equip!

1

Joan Montero @joanmontero.bsky.social · Jul 11

Parece un déja-vu con respecto a la DANA si no fuese porque que en Texas no había nadie para avisar y en Valencia si. Pero ambas desgraciad tienen en común que la incompetencia cuesta vidas

4

Joan Montero @joanmontero.bsky.social · Jul 11

Delighted to see good research highlighted on TV @som.3cat.cat
Congratulations @tceliaterrassa.bsky.social and team! Hope your findings help to better treat metastatic breast cancer patients.
www.3cat.cat/324/cancer-d...

Càncer de mama: identifiquen les cèl·lules que actuen com a llavors de la metàstasi

Investigadors de l'Hospital del Mar vinculen per primer cop una proteïna a la metàstasi en el càncer de mama i obren la porta a tractaments preventius

www.3cat.cat

1

Joan Montero @joanmontero.bsky.social · Jul 10

Osti, perquè em dius que es gazpacho però podria ben bé ser crema de pèsols

1 1

Reposted by Joan Montero

Manuel Collado @manuel-collado.bsky.social · Jul 10

This is going to be a really cool meeting with great invited speakers, but also offering the possibility to showcase your work independently of your career stage.
It will also be loads of fun in Barcelona, with the most friendly and welcoming community ☺️
Rush to register at senescel2025.senescel.org

2 4

Joan Montero @joanmontero.bsky.social · Jul 2

✨ Excited to announce a talk by Rita Fior, PhD on "Zebrafish Avatars for Personalized Medicine & Discovery of Innate Immune Mechanisms"! Join us next Wednesday, July 9, 2025, at 12 PM EDT, organized by @thesfpm.bsky.social. Don't miss it!
www.sfpm.io/seminars

Seminars | SFPM

The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.

www.sfpm.io

Joan Montero @joanmontero.bsky.social · Jun 27

🚨 New Article Alert! Dive into a fantastic review by several @thesfpm.bsky.social members on how new technologies and functional approaches are revolutionizing personalized cancer treatment. Don't miss out on this game-changing insight!

www.nature.com/articles/s41...

Acquired resistance in cancer: towards targeted therapeutic strategies - Nature Reviews Cancer

Acquired therapeutic resistance is a key contributor to cancer treatment failure, requiring new approaches to address its complex mechanisms. In this Roadmap, Soragni, Knudsen and colleagues discuss t...

www.nature.com

1 3

Joan Montero @joanmontero.bsky.social · Apr 28

Congratulations Sandra and team! Fantastic work!

Reposted by Joan Montero

Elizabeth McKenna @elizsmckenna.bsky.social · Apr 28

Online now concurrent with the #AACR25 oral presentation by Cancer Discovery Early Career Award Winner @Sandra_Misale: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations doi.org/10.1158/2159...

2 1 10

Joan Montero @joanmontero.bsky.social · Apr 15

Quote of the day: “If you think research is expensive, try disease.” Mary Lasker

1 2

Joan Montero @joanmontero.bsky.social · Apr 9

Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Read the summary here:

web.ub.edu/en/web/actua...

New advances in the fight against the most common form of lung cancer

web.ub.edu

6

Joan Montero @joanmontero.bsky.social · Mar 21

Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Congratulations to Dr. Martín and to all our collaborators
@ub.edu @ibecbarcelona.eu @hospitalclinic.bsky.social CIBERBBN
rdcu.be/eennu

Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer

Cell Death & Disease - Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer

rdcu.be

1 1

Joan Montero @joanmontero.bsky.social · Mar 11

Do not miss this great talk tomorrow at 5pm CET (12pm EDT): Zinaida Perova (EMBL) "Leveraging CancerModels.Org: Enhancing Precision Oncology Through Collaborative Cancer Model Resources". @thesfpm.bsky.social

www.sfpm.io/seminars

1 1

Joan Montero @joanmontero.bsky.social · Mar 8

Happy International Women’s day to all the brave, intelligent, loving, amazing women worldwide!

1

Joan Montero @joanmontero.bsky.social · Feb 13

🚀 Exciting news! Our new research lab website is live! 🌐 Explore cutting-edge projects, publications, and more. Visit us at themonterolab.com

Home | Montero Lab

The Montero Lab at the University of Barcelona's Department of Biomedical Sciences is dedicated to exploring the biology of cancer metastasis.

themonterolab.com

Reposted by Joan Montero

Cristina Muñoz Pinedo @crismunozp.bsky.social · Feb 4

Papers on cell death from January 2025
Caspases, pyroptosis, apoptosis, cytotoxicity, ferroptosis, necroptosis, Bcl-2 family and more!
ApoList
celldeath.wordpress.com/2025/02/04/a...

ApoList – January 2025

Caspases TIR signaling activates caspase-like immunity in bacteria – François Rousset, Ilya Osterman, Tali Scherf, Alla H. Falkovich, Azita Leavitt, Gil Amitai, Sapir Shir, Sergey Malitsky, M…

celldeath.wordpress.com

4 8

Joan Montero @joanmontero.bsky.social · Feb 4

On #WorldCancerDay #WCD2025 and every day, our lab is committed to finding a cure for cancer through groundbreaking research and advanced functional precision medicine. Together, we can find a treatment for each patient and beat cancer @ub.edu @thesfpm.bsky.social

1 2

Reposted by Joan Montero

The Society for Functional Precision Medicine @thesfpm.bsky.social · Jan 29

An exciting multicenter phase 2 functional precision medicine clinical trial showing how a rapid ex vivo venetoclax sensitivity assay was the strongest predictor for a favorable treatment response and survival in relapsed/refractory secondary AML

ashpublications.org/blood/articl...

Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial

Key PointsBlast-specific ex vivo venetoclax sensitivity correlated strongly with treatment responses and predicted longer survival.VenEx trial showed that

ashpublications.org

3 3

Joan Montero @joanmontero.bsky.social · Jan 22

Moltes felicitats a tot l’equip!

1

Reposted by Joan Montero

Universitat de Barcelona @ub.edu · Jan 22

#RecercaUB | 🔬 Un estudi liderat per la #UniBarcelona descriu un mecanisme per eliminar les cèl·lules perjudicials originades per tractaments oncològics

📷 Dirigeix el treball Joan Montero. La primera autora és Clara Alcon, tots dos de @medicinacs-ub.bsky.social.

👉 web.ub.edu/web/actualit...

Descriuen un mecanisme per poder eliminar les cèl·lules perjudicials originades per tractaments oncològics

Després de tractar un tumor amb quimioteràpia i radioteràpia, es poden originar unes cèl·lules que es coneixen com a senescents. Són cèl·lules que no es divideixen, estan involucrades en el procés d’envelliment i són resistents a la mort cel·lular, però encara són actives metabòlicament en el cos humà. Quan s’hi acumulen, poden posar en risc la recuperació dels pacients. Ara, una recerca liderada per la UB descriu per primer cop un mecanisme molecular que podria impulsar el disseny d’estratègies per eliminar les cèl·lules senescents en els pacients oncològics.

web.ub.edu

4 10

Joan Montero @joanmontero.bsky.social · Jan 14

Thrilled to receive the prestigious ICREA Acadèmia award! A heartfelt thank you to everyone at @ub.edu & ICREA - Institució Catalana de Recerca i Estudis Avançats who made this possible.

Universitat de Barcelona @ub.edu · Jan 14

#RecercaUB | 🙌 El programa ICREA Acadèmia distingeix 1️⃣6️⃣ membres de la #UniBarcelona, que esdevé la institució que més ajuts rep en aquesta convocatòria.

🔬 Cadascun obtindrà 40.000 euros anuals durant 5 anys per impulsar la seva carrera investigadora.

👏 L’enhorabona!

👉 web.ub.edu/web/actualit...

1